Pfizer Global Medical Grants, in collaboration with the National Comprehensive Cancer Network’s (NCCN) Oncology Research Programme (ORP), has jointly awarded funding to nine projects to improve quality of breast cancer care.

NCCN is a not-for-profit alliance comprising 27 major cancer centres focused on patient care, research and education, and aims at enhancing the quality, effectiveness and efficiency of cancer care so that people can live improved lives.

The projects focus on the use of clinical care pathways to implement quality improvement (QI) initiatives along the continuum of care for underserved patients with breast cancer.

Some of the projects will concentrate on evaluating care choices, including the way to maximise chemotherapy delivery, manage symptoms, adhere to guidelines, improve clinical pathways and use shared decision-making.

Other projects focus on specific patient groups, such as African Americans, younger women and patients living in rural areas.

NCCN ORP Clinical Operations director Susan Most said: “Our request for proposals (RFP) specifically sought out centres that focus on treating underserved patients with cancer.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
“Our request for proposals (RFP) specifically sought out centres that focus on treating underserved patients with cancer.”

“By highlighting technological advances and multidisciplinary collaboration, we hope to encourage the widespread adoption of best practices for reducing costs and improving quality in breast cancer patient care.”

More than 90 letters of intent were submitted to the RFP, of which 23 full proposals were requested for review.

Led by NCCN, the review committee for the projects included a medical representative from Pfizer.

Slated to commence in January next year, the projects will continue for a period of two years, during which each of them will have to provide evidence of scalability and sustainability.

Data based on their outcomes will be assessed and disseminated in early 2020.

The current partnership is the third collaboration between NCCN ORP and Pfizer.